HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Echocardiographic evaluation of mitral durability following valve repair in rheumatic mitral valve disease: impact of Maze procedure.

AbstractOBJECTIVE:
The data on echocardiographic evaluation of mitral durability after rheumatic mitral repair is scarce.
METHODS:
A total of 193 patients (mean age, 39.4 ± 12.8 years; 154 females) who underwent mitral valve repair for rheumatic valve disease from 1997 to 2010 were included in the study. A Maze operation was performed in 90.3% (n = 102) of the patients with atrial fibrillation (n = 113). Survival, valve-related complications, and echocardiographic data were evaluated.
RESULTS:
Mitral regurgitation was the predominant disease in 75.6% of patients (n = 146). There was one early death (0.5%) . During the mean follow-up period of 76.7 ± 45.6 months, there were 9 late deaths and 5 mitral reoperations. Valve-related, event-free survival at 10 years was 85.5% ± 3.3%. In serial postoperative echocardiographic evaluations (mean follow-up duration, 53.7 ± 43.5 months), 40 patients showed either mitral regurgitation (>mild; n = 31) or mitral stenosis (mitral valve area ≤1.5 cm(2); n = 9). At 10 years, 66.4% ± 5.4% of the patients did not have moderate to severe mitral dysfunction. By multivariate analysis, no Maze operation for atrial fibrillation was an independent predictor of mitral dysfunctions (hazard ratio, 3.72; 95% confidence interval, 1.47-9.42; P = .005), whereas the presence of hypertension had borderline significance (hazard ratio, 3.15; 95% confidence interval, 0.96-10.38; P = .059).
CONCLUSIONS:
Although rheumatic mitral repair showed excellent long-term clinical outcomes, a significant proportion of patients experienced moderate to severe mitral dysfunctions postoperatively. Atrial fibrillation without a Maze procedure increased significantly the risks of mitral dysfunctions and adverse outcomes. Therefore, routine performance of a Maze procedure is warranted in the presence of atrial fibrillation whenever possible.
AuthorsGwan Sic Kim, Chee Hoon Lee, Joon Bum Kim, Sung-Ho Jung, Suk Jung Choo, Cheol Hyun Chung, Jae Won Lee
JournalThe Journal of thoracic and cardiovascular surgery (J Thorac Cardiovasc Surg) Vol. 147 Issue 1 Pg. 247-53 (Jan 2014) ISSN: 1097-685X [Electronic] United States
PMID23177125 (Publication Type: Journal Article)
CopyrightCopyright © 2014 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.
Topics
  • Ablation Techniques (adverse effects, mortality)
  • Adult
  • Atrial Fibrillation (diagnosis, mortality, surgery)
  • Disease-Free Survival
  • Echocardiography, Doppler
  • Female
  • Heart Valve Prosthesis Implantation (adverse effects, mortality)
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Mitral Valve (diagnostic imaging, surgery)
  • Mitral Valve Annuloplasty (adverse effects, mortality)
  • Mitral Valve Insufficiency (diagnostic imaging, mortality, surgery)
  • Mitral Valve Stenosis (diagnostic imaging, mortality, surgery)
  • Multivariate Analysis
  • Postoperative Complications (mortality, surgery)
  • Predictive Value of Tests
  • Proportional Hazards Models
  • Reoperation
  • Retrospective Studies
  • Rheumatic Heart Disease (diagnostic imaging, mortality, surgery)
  • Risk Factors
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: